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Introduction
NOD2, a member of the Nod-like receptor family of leucine-
rich repeat proteins, is expressed in epithelial and immune cells, 
where it functions as an innate pathogen sensor with specific-
ity for bacterial muramyl dipeptide.1-3 The fact that NOD2 plays 
an important role in host inflammatory immune responses was 
highlighted by the finding that several NOD2 polymorphisms 
are associated with Crohn disease (CD),4-7 a type of inflam-
matory bowel disease. Three polymorphisms (L1007finsC, 
R702W, and G908R) in NOD2 that are associated with CD 
have been shown to impair cellular responses to bacterial pepti-
doglycans.5,6,8 NOD2 interacts with and recruits the autophagy 
protein ATG16L1/autophagy-related 16-like 1 to sites of bacte-
rial entry at the plasma membrane in cultured human epithe-
lial cells.9 Notably, the most common NOD2 polymorphism 
associated with CD results in impaired recruitment of ATG16L1 
to the bacterial entry site and much less bacterial autophagy,9,10 
suggesting an epistatic relationship between NOD2 and the 
autophagy pathway.11,12 Other evidence for a connection between 
NOD2 and ATG16L1 comes from recent data demonstrating 
that whereas mice deficient for ATG16L1 (Atg16l1HM ; Atg16l1 
hypomorphic mice) are protected from infection with a com-
mon intestinal pathogen, Citrobacter rodentium, this protection 
is reversed in mice that also lack Nod2.13
This unexpected role for ATG16L1 in infection—loss of the 
gene-conferring protection rather than increased susceptibil-
ity—was first reported by our group in the case of urinary tract 
infections (UTIs),14 one of the most common infectious dis-
eases in humans. UTIs are primarily caused by uropathogenic 
Escherichia coli (UPEC), and their progression has been well 
described in a murine model.15 UPEC invasion into the bladder 
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NOD2 (nucleotide-binding oligomerization domain containing 2) functions as a pathogen sensor and is involved in 
development of crohn disease, a form of inflammatory bowel disease. NOD2 functions in concert with the autophagy 
protein aTG16L1, which is also implicated in crohn disease. Recently, we identified a novel protective role of aTG16L1 
deficiency in uropathogenic Escherichia coli-induced urinary tract infections (UTis), which are common infectious dis-
eases in humans. Given the known roles of NOD2 in recruiting aTG16L1 to the bacterial entry site, autophagy induction, 
and crohn disease, we hypothesized that NOD2 may also play an important role in UTi pathogenesis. instead, we found 
evidence that NOD2 is dispensable in the pathogenesis of UTis in mice and humans. First, loss of Nod2 did not affect the 
clearance of bacteriuria and the recruitment of innate immune cells to the bladder. second, we showed that, although 
nod2−/− mice display increased kidney abscesses in the upper urinary tract, there were no increased bacterial loads or per-
sistence in this niche. Third, although a previous study indicates that loss of Nod2 reverses the protection from intestinal 
infection afforded by loss of aTG16L1 in mice, we found NOD2 deficiency did not reverse the aTG16L1-deficiency-induced 
protection from UTi. Finally, a population-based study of a cohort of 1819 patients did not reveal any association of NOD2 
polymorphisms with UTi incidence. Together, our data indicated that NOD2 is dispensable for UTi pathogenesis in both 
mice and humans and does not contribute to aTG16L1-deficiency-induced resistance to UTi in mice.
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mucosal lining results in formation of intracellular bacterial 
communities (IBCs) within the epithelial cells. The host defense 
response includes exfoliation of these cells into the bladder 
lumen (where they are noted in the urine of infected mice and 
humans16) to reduce bacterial load, an increase in expression of 
proinflammatory cytokines, and influx of innate immune cells. 
We observed that mice deficient for ATG16L1 cleared their bac-
terial load more rapidly than their wild-type counterparts and 
displayed faster epithelial regeneration and an enhanced innate 
immune response.
As with NOD2, T300A polymorphism in ATG16L1 is linked 
to CD.17-20 Studies in cultured human epithelial cells suggest that 
the ATG16L1T300A allelic variant leads to a defect in xenophagy, 
or antibacterial defense.21-24 Given the interplay of NOD2 and 
ATG16L1 in linking bacterial sensing and induction of auto-
phagy and their significant roles in both CD pathogenesis and 
the response to an intestinal pathogen, we hypothesized that 
NOD2 functions in regulating the UPEC pathogenic cycle in 
UTIs. Instead, we show here that NOD2 is dispensable for the 
murine host response to UTI in the bladder. Furthermore, loss of 
NOD2 does not reverse the ATG16L1-deficiency-induced pro-
tection from UTI. Finally, we observed no association between 
NOD2 polymorphisms and UTI incidence in humans. Our data 
indicated that, contrary to the situation in the intestine, NOD2 
and ATG16L1 play distinct roles in disease development in the 
urinary tract mucosa.
Results
NOD2 is dispensable for the clearance of bacteriuria in the 
bladder mucosa
To determine whether the absence of Nod2 affects the UPEC 
pathogenic cycle in a similar manner as ATG16L1 deficiency, 
we induced UTI in adult female nod2−/− and wild-type mice by 
transurethrally inoculating them with 107 colony-forming units 
(CFU) of a clinical cystitis UPEC isolate, UTI89.25,26 The prog-
ress of UPEC-induced UTI was monitored by measuring shed-
ding of bacteria into the urine (i.e., bacteriuria). We found that 
nod2−/− mice exhibited a similar urine CFU profile to control 
mice during the whole time course (Fig. 1A).
We previously showed that ATG16L1-deficiency-induced 
fast clearance of UTI was associated with increased recruitment 
of monocytes to infected bladders and a potent proinflamma-
tory response.14 To examine whether Nod2 deficiency alters the 
recruitment of innate immune populations upon infection, we 
examined urine of nod2−/− mice before and 6 h post inocula-
tion (hpi) and found that urine from infected nod2−/− mice con-
tained similar numbers of neutrophils (Fig. 1B) and monocytes 
(Fig. 1C) as infected control mice, though we noted a trend 
toward reduced influx.
Upon infection and during the acute stage of infection (0 to 
72 h), UPEC invade the superficial uroepithelial cells where they 
replicate rapidly and establish IBCs.27 A subset of UPEC sur-
vives and establishes long-term reservoirs within the urothelium. 
These quiescent intracellular reservoirs (QIRs) are enclosed 
within vesicular compartments decorated with late endosomal/
lysosomal markers such as LAMP1 (lysosomal-associated mem-
brane protein 1); UPEC within QIRs can re-emerge to seed 
recurrent UTIs.25 To examine whether Nod2 deficiency affects 
colonization of the bladder and the establishment of IBCs and 
QIRs, we quantified the number of IBCs in the bladder at 6 
hpi. We observed that bladders from nod2−/− mice had similar 
numbers of IBCs as those from wild-type mice (Fig. 1D). We 
next examined control and nod2−/− bladders at 14 d post inocu-
lation (dpi) to determine whether absence of Nod2 affects the 
establishment of QIRs. We found that bladders of nod2−/− mice 
harbored slightly fewer LAMP1-positive QIRs than bladders of 
control mice, but the difference was not statistically significant 
(Fig. 1E).
Previous work has shown that bacterial QIRs occupy 
autophagosomal compartments28 and that ATG16L1 deficiency 
results in reduced QIR formation and significant alterations in 
the urothelial cell architecture.14 In contrast, transmission elec-
tron microscopy (TEM) analysis revealed only subtle differences 
in ultrastructural architecture between bladders of wild-type and 
nod2−/− mice (Fig. 1F–H).
Urothelial tissue regeneration is an important step in the reso-
lution of UTIs.26 To determine whether or not NOD2 plays a 
role in this process, we analyzed bladder tissue sections from con-
trol and nod2−/− mice at 14 dpi. Hematoxylin and eosin (H&E) 
staining revealed that the bladders of both control and nod2−/− 
mice displayed newly regenerated, terminally differentiated, 
nonproliferating superficial cells and resolution of inflammation 
(Fig. 1I). Immunolocalization of the lumenal surface protein 
UPK3 (uroplakin 3) demonstrated that these bladders also dis-
played regenerated superficial cells (Fig. 1J). Together, our data 
show that NOD2 is dispensable for the clearance of bacteriuria 
and does not affect UPEC’s ability to establish an acute infection 
or persist in the bladder.
Kidneys of UPEC-infected Nod2-deficient mice have high 
inflammatory scores and increased incidence of abscesses
After bacterial colonization of the bladder, UTIs can at times 
ascend to the kidneys, although in C57BL/6 mice this is rela-
tively uncommon. We found that a large percentage of kidneys 
from nod2−/− mice than from wild-type mice had abscesses at 
14 dpi (Fig. 2A), a time when the bladders have cleared infec-
tion. Furthermore, the inflammation scores were significantly 
higher in kidneys of nod2−/− mice than in those from con-
trols (Fig. 2B). H&E staining of kidneys from nod2−/− mice 
revealed abscessed areas with neutrophil influx (Fig. 2C and 
D). Immunofluorescence analysis revealed collections of bacte-
ria tightly packed between tubular epithelial cells of the kidney 
(Fig. 2E and F) in multiple kidneys. Large extracellular bacterial 
biofilm-like communities were observed filling renal tubules in 
nod2−/− but not in control mice (Fig. 2G and H). Given these 
data, we next determined whether Nod2 deficiency was asso-
ciated with increased bacterial titers and bacterial persistence 
in the kidneys. However, we found no significant difference 
between control and nod2−/− mice in bacterial loads in the kidney 
tissue at 14 dpi (Fig. 2I).
Nod2 deficiency does not reverse the ATG16L1-deficiency-
induced protection from UTI
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Figure 1. Loss of Nod2 does not affect the course of UTi. (A) cFU counts of bacteriuria plotted as mean ± seM of the Log10 value at 1–14 dpi with UTi89. *P 
< 0.05 by 2-way aNOVa with Bonferroni post-test. n = 5 to 15 mice/timepoint/genotype; n = 5 experiments. (B) Neutrophil counts in the urine. Bars repre-
sent mean ± seM; n = 4 or 5 mice/time point; n = 2 experiments. (C) Monocyte counts in the urine. Bars represent mean ± seM; n = 4 to 5 mice/time point; 
n = 2 experiments. (D) Quantification of iBcs in bladders from control vs. nod2−/− mice at 6 hpi. (E) Quantification of QiRs in bladders from control vs. 
nod2−/− mice at 14 dpi. n = 8 sections/bladder; n = 32 and 20 bladders from c57BL/6 and nod2−/− mice, respectively. (F) TeM of control and nod2−/− superfi-
cial cell ultrastructure. Panels representative of 10- to 15-sq µm regions were examined in n = 3 mice. scale bar: 1 µm. (G and H) Quantification of MVBs 
(G) and lysosomes (H) in TeM images. Bars represent mean ± seM (i) h&e stained bladders from control and nod2−/− mice at 14 dpi. scale bar: 10 µm. (J) iF 
imaging analysis of control and nod2−/− urothelium stained with an antibody to UPK3 (red), and biz-benzimide to highlight nuclei (blue). scale bar: 10 µm.
A recent study demonstrates that whereas mice deficient for 
ATG16L1 are protected from infection with a common intestinal 
pathogen, Citrobacter rodentium, this protection is reversed in 
mice that also lack Nod2.13 To explore the possibility that loss of 
Nod2 might reverse the ATG16L1-deficiency-induced protection 
from UTIs, we compared bacteriuria in Atg16l1HM and Atg16l1HM 
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Figure  2. Nod2 deficiency is 
associated with kidney abscess 
formation during UTi. (A) 
Quantification of the percentage 
of mice with kidney abscesses at 
14 dpi. (B) inflammation scores of 
kidneys from control and nod2−/− 
mice. n = 20 for control; n = 14 for 
nod2−/−; **P < 0.01. (C and D) h&e 
staining of kidneys from control 
(C) and nod2−/− (D) mice. arrow 
indicates a region of neutrophil 
influx. scale bar: 63 m. (E–H) 
immunofluorescence staining of 
UPec (green), e-cadherin (cyan), 
and nuclei (blue) in kidneys of 
control (E and G) and nod2−/− (F 
and H) mice. arrow indicates 
clumps of bacteria and neu-
trophils inside renal tubules. (I) 
cFU counts of bacterial load in 
the kidney plotted as mean ± 
seM of the Log10 value at 1 at 14 
dpi, n = 4 to 9 mice/group, n = 3 
experiments.
nod2−/− double-mutant mice. 
We observed that the double-
mutant mice were protected 
to the same extent as the 
Atg16l1HM mice and that loss 
of Nod2 did not abrogate the 
ATG16L1-deficiency-induced 
protection (Fig. 3).14
NOD2 polymorphisms are 
not associated with the inci-
dence of UTI
It has been shown that 
NOD2 polymorphisms are 
associated with susceptibil-
ity to CD.5,6,29 To examine 
whether there is an associa-
tion between NOD2 poly-
morphisms and the incidence 
of UTI, we performed an 
association study of NOD2 
polymorphisms in a large 
Dutch population cohort. Data on 3 NOD2 polymorphisms, 
rs2066844 (R702W), rs2066845 (G908R), and rs2076756, and 
questionnaire data on UTIs, including those treated with anti-
biotics, were extracted for 1,819 human subjects. We found that 
these NOD2 variants show no association with UTI incidence 
(Fig. 4; Table 1).
Figure  3. Nod2 deficiency does not reverse the aTG16L1-deficiency-
induced protection from UTi. cFU counts of bacteriuria plotted as mean 
± seM of the Log10 value at 1–14 dpi with UTi89. *P < 0.05 by 2-way 
aNOVa with Bonferroni post-test. n = 5 to 15 mice/timepoint/genotype; 
n = 5 experiments.
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Discussion
Here, we used a murine model to demonstrate that NOD2 is 
dispensable for the host response to UPEC-induced infections 
in the bladder and does not affect recruitment of myeloid cells 
to combat infection. Furthermore, although our data suggest 
that NOD2 may be required for prevention of ascending infec-
tion into the kidney, overall, loss of Nod2 did not affect bacterial 
load and persistence in the kidneys. Thus, NOD2 is dispens-
able for both lower and upper urinary tract infection. This is in 
contrast to the study by Kim et al.,30 which shows that nod2−/− 
mice are more vulnerable than wild-type mice to oral infection 
with Citrobacter rodentium because of impaired recruitment of 
monocytes to the intestine. Kobayashi et al.31 also show that 
nod2−/− mice challenged orally with Listeria monocytogenes are 
susceptible to infection; however, no significant difference in 
survival between nod2−/− and wild-type mice was noted upon 
systemic challenge, suggesting a tissue-specific effect. Similarly, 
Geddes et al.32 demonstrate that NOD2 can modulate inflam-
mation and mediate efficient clearance of bacteria from mucosal 
tissue during Salmonella typhimurium-induced colitis.
Other studies suggest that NOD2 is not essential for host 
defense to pathogens in general. For example, studies from Jeong 
et al.33 show that NOD2 is not critical for initiating the innate 
immune response to Yersinia enterocolitica infection as bacterial 
clearance and serum cytokine production levels upon systemic 
infection are indistinguishable between nod2−/− and control 
mice. However, Meinzer et al. show that NOD2 contributes to 
Figure 4. NOD2 polymorphisms are not associated with the incidence of UTi. (A) Percentage of patients with regular bladder infections among NOD2 
sNP variant groups. (B) Percentage of patients with UTis treated with antibiotics among NOD2 sNP variant groups. Person chi-square test and Fisher 
exact Test indicated that none of the differences were statistically significant.
Table 1. absolute number (% within genotype group) of subjects with 
regular bladder infections/UTi treated with antibiotics among NOD2  
variant groups.
Regular bladder 
infection
UTI treated with 
antibiotics
Variant genotype Male Female Male Female
rs2066844 cc 20 (2.6) 124 (15.0) 115 (21.2) 304 (52.0)
rs2066844 cT 6 (5.7) 11 (13.4) 15 (23.4) 28 (52.8)
rs2066844 TT 0 (0) 0 (0) 1 (100.0) 1 (50.0)
rs2076756 aa 14 (3.2) 82 (16.9) 66 (21.6) 183 (54.0)
rs2076756 aG 8 (2.1) 42 (11.8) 56 (21.8) 123 (49.4)
rs2076756 GG 4 (5.9) 11 (16.2) 8 (19.0) 27 (52.9)
rs2066845 cc - - - -
rs2066845 cG 1 (3.2) 3 (10.0) 3 (15.8) 7 (31.8)
rs2066845 GG 25 (2.9) 132 (15.0) 128 (21.7) 326 (52.8)
Data provided for males and females separately. all p for Pearson chi-
square or Fishers exact test > 0.05.
the susceptibility to Y. pseudotuberculosis in mice34 and that Y. 
pseudotuberculosis subverts NOD2 signaling to promote dissemi-
nation.35 NOD2 is also dispensable for the control of Brucella 
abortus during systemic in vivo infection.36 Thus, NOD2 mainly 
plays key roles in intestinal pathogenesis, and this regulation 
may be pathogen-specific as well as tissue-specific.
Our findings revealed that NOD2 and ATG16L1 play 
different roles in the UPEC pathogenic cycle; whereas 
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ATG16L1-deficient mice clear UPEC faster than wild-type 
mice, nod2−/− mice were not protected from UTI. Thus, in dou-
bly mutant Atg16l1HM nod2−/− mice, the fast clearance of bacte-
riuria is mediated by ATG16L1 deficiency but not the lack of 
Nod2. Our findings suggest that Nod2 deficiency does not affect 
invasion and colonization of the bladders, and the absence of 
Nod2 does not affect the formation of protected niches contain-
ing UPEC during the latent stage of infection. This again is in 
direct contrast to the striking phenotypes elicited with ATG16L1 
deficiency, suggesting that NOD2 and ATG16L1 play divergent 
roles in the UPEC pathogenic cycle.
Cadwell and colleagues have recently shown that ATG16L1-
deficient mice are resistant to Citrobacter rodentium-induced 
infection,13 consistent with our observation that ATG16L1 
deficiency confers protection from UTI.14 However, unlike our 
observation that NOD2 is dispensable for ATG16L1-deficiency-
mediated protection from UTI, loss of Nod2 abrogates the 
protective effect of ATG16L1 deficiency in Citrobacter roden-
tium infection.13 Thus, the outcome of the interaction between 
NOD2 and ATG16L1 may also be tissue- or pathogen- specific. 
A recent study using an influenza virus infection model suggests 
that NOD2-RIPK2-signaling limits immunopathology through 
autophagy-mediated removal of damaged mitochondria. This 
study indicates that the intersection between these pathways 
can be immuno-suppressive rather than directly antibacterial.37 
NOD2 signaling is involved in other important modulatory 
functions such as secreting antimicrobial peptides and activating 
adaptive immunity.31,38,39
There is a large body of evidence suggesting interactions 
between NOD2 and ATG16L1 in host defense against intestinal 
infection in cultured cells, mouse models, and human associa-
tion studies. Plantinga et al. show that the ATG16L1 polymor-
phism modulates proinflammatory cytokine response selectively 
upon activation of NOD2.11 However, our study highlights that 
this is not a universal paradigm as NOD2 polymorphisms were 
not associated with a common infection of the urinary tract 
mucosa. Thus, mucosa-specific studies of NOD2 and ATG16L1 
polymorphisms associated with inflammatory disease are war-
ranted to elucidate the complex factors, including genetic dif-
ferences, which are required in different disease models and in 
different mucosal niches.
Materials and Methods
Mice
All animal protocols were approved by the animal studies 
committee of the Washington University School of Medicine 
(Animal Welfare Assurance, A-3381-01). Mice were maintained 
under specified pathogen-free conditions in a barrier facility and 
under a strict 12 h light/dark cycle. Atg16l1HM mice were gener-
ated as described previously.40 Atg16l1HM nod2−/− mice were gen-
erated by crossing nod2−/− mice31 to Atg16l1HM mice. C57BL/6 
mice were used as the wild-type strain.
Bacterial strains, mouse inoculations, and urinalysis
Adult female mice (8 to 10 wk old) were anesthetized and 
inoculated via transurethral catheterization with 107 CFU of 
UTI89 in phosphate-buffered saline. Urinalysis and bacte-
rial titering of urine and tissues were performed as described 
previously.15
Histochemical and immunofluorescence analyses
Bladders were processed as described previously.26 The follow-
ing primary antibodies were used: 1) rabbit polyclonal antibody 
to E. coli (United States Biological, E3500-20), 2) mouse mono-
clonal antibody to CDH1 [cadherin 1, type 1, E-cadherin (epi-
thelial)] (BD Bioscience, 610182), 3) rat monoclonal antibody 
to LAMP1 (clone ID4B; Developmental Studies Hybridoma 
Bank), and 4) antibody to UPK3 (Fitzgerald, 10R-U103a). 
Antigen-antibody complexes were detected with Alexa Fluor 
488, 594, and 647-conjugated secondary antibodies (Invitrogen, 
A21206, A-11007, A20990). Images were obtained with a 
Zeiss Apotome microscope (Zeiss) at 10 to 20× and 40 to 63× 
magnifications.
QIR quantification
Eight separate 5-μm serial sections over a thickness of 300 
μm were immunostained with antibodies against E. coli, 
LAMP1, and E-cadherin and imaged at 63× on a Zeiss Apotome 
microscope (Zeiss). The total number of LAMP1-positive UPEC 
reservoirs per bladder was counted.
Transmission electron microscopy
The whole bladder was processed as described previously.14 
The numbers of lysosomes and multivesicular bodies (MVBs) 
were determined and normalized to total surface area of the 
region examined by using JEOL 1200 EX II transmission elec-
tron microscope (JEOL USA, Inc) equipped with an AMT 8 
megapixel digital camera (Advanced Microscopy Techniques).
Neutrophil and monocyte counts in urine
Urine was collected before and after infection. The diagnostic 
lab in the Department of Comparative Medicine, WUSM used a 
HEMAVET® 950, Veterinary 5 part WBC Hematology System 
(Americas Drew Scientific Inc) to determine neutrophil and 
monocyte counts.
NOD2 polymorphism analysis
Nijmegen Biomedical Study (NBS) (http://www.nijmegen-
biomedischestudie.nl) is a population-based survey conducted 
by the Department for Health Evidence and the Department 
of Clinical Chemistry of the Radboud University Nijmegen 
Medical Centre, The Netherlands. 21,756 age- and sex-stratified 
randomly selected inhabitants of the municipality of Nijmegen, 
the Netherlands, received an invitation to fill out a postal 
questionnaire on lifestyle and medical history, and to donate a 
blood sample. For this study, we used the subset of 1,980 par-
ticipants from the NBS that was selected to serve as controls in 
genome-wide association studies and were genotyped by using 
the Illumina HumanHap370CNV-Duo BeadChip. Genotype 
data were imputed (IMPUTE software version 0.5) by using the 
CEU HapMap Phase II data as reference.41 Imputed genotype 
probabilities for those 1,819 participants that passed quality 
control were extracted for NOD2 variants rs2066844 (R702W) 
and rs2066845 (G908R) and transformed into hard calls using 
a genotype probability threshold of ≥ 0.9; measured genotype 
data was extracted for rs2076756. All NOD2 variants followed 
Hardy-Weinberg equilibrium. QN data on i) recurrent UTIs 
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diagnosed by a physician (available for n = 1790) and ii) UTIs 
treated with antibiotics (available for n = 1248), were extracted 
for this study.
Statistical analyses
To assess the significance of a difference between groups, 
Graph Prism software was used to perform 2-sample, unpaired 
t tests. For time-course studies, the standard error (SE) used in 
the t test was estimated by ANOVA, and 2-sample tests were 
performed at individual time points. To control for false posi-
tives, Bonferroni adjusted P values at individual time points are 
reported. A P value of less than 0.05 was considered to be signifi-
cant. To evaluate the association between overall UTIs or UTIs 
treated with antibiotics and the NOD2 variants in the NBS, 
cross-tabs were generated and Pearson chi-square or Fisher exact 
tests performed, for men and women separately [IBM SPSS 
Statistics for Windows 20 (IBM Corp.)].
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